tfa 18:2 t not further defined

Trans fatty acids (TFAs), including the subtype 18:2 trans fatty acids, are geometric isomers of unsaturated fatty acids that contain at least one carbon–carbon double bond in the trans configuration rather than the usual cis configuration. This structural change results in a straighter carbon chain, which influences how these molecules interact with enzymes and membranes in the body. Specifically, the 18:2 designation refers to fatty acids with an 18-carbon chain and two double bonds, both in the trans orientation. These trans isomers can occur naturally, such as in the fats of ruminant animals (e.g., cows and sheep) where bacterial biohydrogenation processes produce trans fatty acids in small amounts. Natural TFAs include vaccenic acid and some forms of conjugated linoleic acid (CLA), which can be found in dairy products and meat fat. However, the primary concern with trans fats in human nutrition arises from industrially produced trans fats formed during the partial hydrogenation of vegetable oils, a process developed in the early 20th century to improve shelf life and texture of fats used in processed foods. Partially hydrogenated oils were once widely used in margarines, shortenings, baked goods, and fried snacks because they offered desirable physical properties and extended product stability. These industrial trans fats often included high levels of trans-18:1 and trans-18:2 isomers depending on the oil processed and degree of hydrogenation. Over decades of dietary research, it became clear that high intake of industrial trans fats was associated with adverse cardiovascular outcomes, leading to regulatory actions in many countries to remove partially hydrogenated oils from commercial food production. In the United States, for example, the Food and Drug Administration determined that partially hydrogenated oils are not generally recognized as safe, resulting in their phase-out from most food products. While trace amounts of trans fats from ruminant sources remain in dairy and meat, the dominant public health focus is on eliminating industrial sources due to their disproportionate contribution to negative health effects. In biochemical terms, TFAs are metabolized differently from cis unsaturated fats, often interfering with normal lipid metabolism. They can alter membrane fluidity, lipid signaling pathways, and are known to unfavorably modify blood lipid profiles by raising low-density lipoprotein (LDL) cholesterol and lowering high-density lipoprotein (HDL) cholesterol. Because of this, trans fats are classified as undesirable components of the diet rather than essential nutrients.

Unlike essential fatty acids such as linoleic acid (an omega-6 polyunsaturated fatty acid) or alpha-linolenic acid (an omega-3), trans fatty acids like 18:2 trans do not play beneficial roles in normal human physiology. Instead, extensive evidence indicates that these fats are associated with adverse health outcomes. Mechanistically, the trans configuration of the double bonds alters how these molecules interact with enzymes and receptors involved in lipid metabolism. For example, trans fatty acids are integrated into cell membranes where they can disrupt the normal fluidity and function of lipid bilayers. Additionally, they modify the activity of transcription factors involved in lipid synthesis and inflammation, contributing to pro-inflammatory states and dysregulated lipid profiles. Clinical and observational research shows that diets high in industrial TFAs increase levels of LDL cholesterol and lower HDL cholesterol, both of which are established risk factors for atherosclerotic cardiovascular disease. This effect on blood lipids has been demonstrated in controlled feeding trials and epidemiological studies, prompting health authorities worldwide to recommend minimizing trans fat intake. Beyond impacts on cholesterol, TFAs have been shown to increase markers of systemic inflammation, such as C-reactive protein and pro-inflammatory cytokines like TNF-α and interleukins. These inflammatory changes are implicated in the development of insulin resistance and endothelial dysfunction, contributing to atherogenesis and metabolic syndrome. In prospective cohort studies, higher TFA intake has been correlated with increased risk of coronary heart disease (CHD) events, including nonfatal myocardial infarction and CHD mortality. For example, adipose tissue markers of trans-18:2 TFA were associated with a significantly higher odds of acute myocardial infarction in a Costa Rican cohort, suggesting these specific isomers contribute to cardiovascular risk. Because of these strong associations, health organizations advise that trans fat intake should be as low as possible within a nutritionally adequate diet, advising levels below 1% of total energy intake to reduce CVD risk. While small amounts of naturally occurring TFAs from ruminant sources are still present in some foods, research has not identified specific health benefits of these isomers at typical dietary levels. Earlier studies explored proposed benefits of certain conjugated linoleic acid (CLA) isomers, such as potential effects on body composition or cancer risk modulation, but clinical results remain inconsistent and do not outweigh the established cardiovascular risks associated with total TFA intake. As such, no recognized health benefits warrant recommending trans fatty acid consumption, and dietary guidelines focus solely on reduction and avoidance.

Trans fatty acids are unique among dietary fats in that they are not required for human health and have no established Recommended Dietary Allowance (RDA) or Adequate Intake (AI) because they do not provide nutritional benefits. Instead, health guidelines define limits for safe intake, emphasizing reduction rather than meeting a minimum requirement. The World Health Organization and Dietary Guidelines for Americans recommend that trans fat intake be limited to less than 1% of total daily energy intake for both adults and children, which translates roughly to no more than about 2.2 grams of trans fat per day on a 2,000-calorie diet. This guidance is based on evidence linking higher trans fat consumption with increased risk of coronary heart disease and adverse lipid profiles. Achieving less than 1% of energy intake typically involves choosing foods low in industrial trans fats, avoiding products with partially hydrogenated oils on the ingredients list, and consuming minimally processed whole foods. In practice, regulatory changes have significantly reduced industrial trans fats in the food supply of many high-income countries, further lowering population-level intakes. The U.S. FDA’s decision to remove partially hydrogenated oils from the list of ingredients generally recognized as safe resulted in widespread reformulation of processed foods, while similar measures have been implemented in other countries. No specific daily value for trans fats is mandated on food labels, though the Nutrition Facts panel in the U.S. lists grams of trans fat per serving to help consumers track intake. A focus on overall dietary patterns that prioritize unsaturated fats from foods like nuts, seeds, avocados, and fish, while minimizing processed fats and fried foods, supports cardiovascular health better than merely calculating grams of specific fatty acids. For infants and young children, trans fat intake is also recommended to be as low as possible, with breastfeeding and age-appropriate whole foods providing beneficial fats while avoiding industrial trans fats. In summary, rather than prescribing a requirement, public health guidance consistently aims to minimize trans fatty acid intake to support cardiovascular health and reduce chronic disease risk.

Common Forms: Not applicable

Typical Doses: Not relevant

When to Take: Not relevant

Best Form: Not applicable